TABLE OF CONTENTS
Volume 101, Issue 6 (June 2006)
Reflections on Medical Practice |
Original Contributions |
Clinical Reviews |
Case Reports |
Letters to the Editor |
Erratum |
Announcement
Methodology
Evidence Based Medicine (EBM) in Practice: Applying Results of Cost-Effectiveness Analyses
Joel H Rubenstein MD, MSc and John M Inadomi MD
Am J Gastroenterol 101: 1169-1171; doi:10.1111/j.1572-0241.2006.00452.x
Reflections on Medical Practice
Functional versus Organic: An Inappropriate Dichotomy for Clinical Care
Douglas A Drossman MD
Am J Gastroenterol 101: 1172-1175; doi:10.1111/j.1572-0241.2006.00592.x
ACG Conflict of Interest Policy
Amy E Foxx-Orenstein DO, FACG, FACP
Am J Gastroenterol 101: 1176-1177; doi:10.1111/j.1572-0241.2006.00633.x
Original Contributions
Esophagus
Temporal Changes in the Endoscopic Frequency of New Cases of Barrett's Esophagus in an Australian Health Region
Bradley J Kendall MBBS, FRACP and David C Whiteman MBBS, PhD
Am J Gastroenterol 101: 1178-1182; doi:10.1111/j.1572-0241.2006.00548.x
Editorial
Short Segment Barrett's Esophagus: Ignorance May Be Bliss
Joel E Richter MD, FACP, MACG
Am J Gastroenterol 101: 1183-1185; doi:10.1111/j.1572-0241.2006.00546.x
Esophagus
Effect of Acid, Pepsin, and Bile Acid on the Stenotic Progression of Traumatized Subglottis
Jong-Lyel Roh MD, PhD, Yong-Won Lee MD and Hee T Park MD
Am J Gastroenterol 101: 1186-1192; doi:10.1111/j.1572-0241.2006.00594.x
Esophagitis: Incidence and Risk of Esophageal Adenocarcinoma—A Population-Based Cohort Study
Annmarie Lassen PhD, Jesper Hallas DMSci and Ove B Schaffalitzky de Muckadell DMSci
Am J Gastroenterol 101: 1193-1199; doi:10.1111/j.1572-0241.2006.00550.x
Stomach
Proton Pump Inhibitor or Testing for Helicobacter pylori as the First Step for Patients Presenting with Dyspepsia? A Cluster-Randomized Trial
Dorte Ejg Jarbol MD, PhD, Jakob Kragstrup MD, DMedSci, PhD, Henrik Stovring MSc, PhD, Troels Havelund MD and Ove B Schaffalitzky de Muckadell MD, DMedSci
Am J Gastroenterol 101: 1200-1208; doi:10.1111/j.1572-0241.2006.00673.x
Editorial
Management of the Dyspeptic Patient: Anything Goes?
Peter Bytzer MD, PhD
Am J Gastroenterol 101: 1209-1210; doi:10.1111/j.1572-0241.2006.00666.x
Stomach
Erythromycin Infusion Prior to Endoscopy for Acute Upper Gastrointestinal Bleeding: A Randomized, Controlled, Double-Blind Trial
Nicholas Carbonell, Arnaud Pauwels, Lawrence Serfaty, Pierre-Yves Boelle, Laurent Becquemont and Raoul Poupon
Am J Gastroenterol 101: 1211-1215; doi:10.1111/j.1572-0241.2006.00582.x
Endoscopy
Endoscopic Ultrasound Restaging After Neoadjuvant Chemotherapy in Esophageal Cancer
Afonso Ribeiro MD, Dido Franceschi MD, Javier Parra MD, Alan Livingstone MD, Mayra Lima MSN, ARNP, Kara Hamilton-Nelson MPH and Bach Ardalan MD
Am J Gastroenterol 101: 1216-1221; doi:10.1111/j.1572-0241.2006.00692.x
Editorial
Endoscopic Ultrasound Classification of Esophageal Cancer After Chemotherapy or Chemoradiotherapy
Gregory Zuccaro Jr MD
Am J Gastroenterol 101: 1222-1223; doi:10.1111/j.1572-0241.2006.00688.x
Endoscopy
Long-Term Follow-Up of Patients with Obscure Gastrointestinal Bleeding After Negative Capsule Endoscopy
Larry H Lai MBChB, Grace LH Wong MBChB, Dorothy KL Chow MBChB, James YW Lau MD, Joseph JY Sung MD, PhD and Wai K Leung MD
Am J Gastroenterol 101: 1224-1228; doi:10.1111/j.1572-0241.2006.00565.x
Long-Term Results with a New Introducer Method with Gastropexy for Percutaneous Endoscopic Gastrostomy
Arno J Dormann MD, Bernd Wejda MD, Stefan Kahl MD, Hans Huchzermeyer MD Prof., Matthias P Ebert MD and Peter Malfertheiner MD Prof.
Am J Gastroenterol 101: 1229-1234; doi:10.1111/j.1572-0241.2006.00541.x
Liver and Biliary Tract
Sexual Dysfunction is Highly Prevalent Among Men with Chronic Hepatitis C Virus Infection and Negatively Impacts Health-Related Quality of Life
Ann Danoff MD, Oona Khan MD, David W Wan MD, Lainie Hurst MD, Daniel Cohen MD, Craig T Tenner MD and Edmund J Bini MD, MPH
Am J Gastroenterol 101: 1235-1243; doi:10.1111/j.1572-0241.2006.00544.x
Resistin Serum Levels Are Associated with Insulin Resistance, Disease Severity, Clinical Complications, and Prognosis in Patients with Chronic Liver Diseases
Eray Yagmur MD, Christian Trautwein MD, Axel M Gressner MD and Frank Tacke MD, PhD
Am J Gastroenterol 101: 1244-1252; doi:10.1111/j.1572-0241.2006.00543.x
Is Congenital Hepatic Fibrosis a Pure Liver Disease?
Özlem Yönem MD, Nihal Özkayar MD, Ferhun Balkanc
MD, Özgür Harmanc MD, Cenk Sökmensüer MD, Osman Ersoy MD and Yusuf Bayraktar MD
Am J Gastroenterol 101: 1253-1259; doi:10.1111/j.1572-0241.2006.00642.x
Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?
Dominique Thabut MD, Sophie Le Calvez MD, Vincent Thibault MD, PhD, Julien Massard MD, Mona Munteanu MD, Vincent Di Martino MD, PhD, Vlad Ratziu MD and Thierry Poynard MD, PhD
Am J Gastroenterol 101: 1260-1267; doi:10.1111/j.1572-0241.2006.00556.x
A Study of Low Dose Peginterferon Alpha-2b with Ribavirin for the Initial Treatment of Chronic Hepatitis C
Edward L Krawitt MD, Stuart R Gordon MD, Norman D Grace MD, Takamaru Ashikaga PhD, Mary Ann Ray BSN, Melissa Palmer MD, Joseph C Yarze MD and Sam Moskowitz MD for the New York New England Study Team
Am J Gastroenterol 101: 1268-1273; doi:10.1111/j.1572-0241.2006.00614.x
Inflammatory Bowel Disease
Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database
Ida Vind, Lene Riis, Tine Jess, Elisabeth Knudsen, Natalia Pedersen, Margarita Elkjær, Inger Bak Andersen, Vibeke Wewer, Peter Nørregaard, Flemming Moesgaard, Flemming Bendtsen and Pia Munkholm the DCCD study group
Am J Gastroenterol 101: 1274-1282; doi:10.1111/j.1572-0241.2006.00552.x
Survival After Colorectal Cancer in Patients with Ulcerative Colitis: A Nationwide Population-Based Danish Study
Ane B Jensen MD, Mette Larsen MD, Mette Gislum MSc, Mette V Skriver MSc, Peter Jepsen MD, Bente Nørgaard MD, PhD and Henrik T Sørensen MD, PhD, DMSc
Am J Gastroenterol 101: 1283-1287; doi:10.1111/j.1572-0241.2006.00520.x
Functional GI
Abnormal Intestinal Permeability in Subgroups of Diarrhea-Predominant Irritable Bowel Syndromes
Simon P Dunlop MD, John Hebden MD, Eugene Campbell MB, Jorgen Naesdal MD, Lars Olbe MD, Alan C Perkins PhD and Robin C Spiller MD
Am J Gastroenterol 101: 1288-1294; doi:10.1111/j.1572-0241.2006.00672.x
Editorial
Mucosal Barrier Defects in Irritable Bowel Syndrome. Who Left the Door Open?
Giovanni Barbara MD
Am J Gastroenterol 101: 1295-1298; doi:10.1111/j.1572-0241.2006.00667.x
Functional GI
Gastrointestinal Symptoms in Families of Patients with an SCN5A-Encoded Cardiac Channelopathy: Evidence of an Intestinal Channelopathy
G Richard Locke III, Michael J Ackerman, Alan R Zinsmeister, Prabin Thapa and Gianrico Farrugia
Am J Gastroenterol 101: 1299-1304; doi:10.1111/j.1572-0241.2006.00507.x
Risk Factors for Fecal Incontinence: A Population-based Study in Women
Adil E Bharucha MD, Alan R Zinsmeister PhD, G Richard Locke MD, Barbara M Seide, Kimberly McKeon MD, Cathy D Schleck and L Joseph Melton III MD
Am J Gastroenterol 101: 1305-1312; doi:10.1111/j.1572-0241.2006.00553.x
Colon
Mismatch Repair Polymorphisms and Colorectal Polyps: hMLH1 -93G>A Variant Modifies Risk Associated with Smoking
Joon-Ho Yu MPH, Jeannette Bigler PhD, John Whitton MS, John D Potter MD, PhD and Cornelia M Ulrich PhD
Am J Gastroenterol 101: 1313-1319; doi:10.1111/j.1572-0241.2006.00551.x
Receipt of Recommended Therapy by Patients with Advanced Colorectal Cancer
Neena S Abraham MD, MSc (EPI), J Travis Gossey MD, Jessica A Davila PhD, Sarah Al-Oudat MD and Jennifer K Kramer PhD
Am J Gastroenterol 101: 1320-1328; doi:10.1111/j.1572-0241.2006.00545.x
Screening for Colorectal Cancer with Flexible Sigmoidoscopy: Is a 5-Yr Interval Appropriate? A Comparison of the Detection of Neoplasia 3 Yr versus 5 Yr After a Normal Examination
Carol A Burke MD, Kareem Elder MD and Rocio Lopez MS
Am J Gastroenterol 101: 1329-1332; doi:10.1111/j.1572-0241.2006.00639.x
Risk Factors for Immediate Postpolypectomy Bleeding of the Colon: A Multicenter Study
Hyun S Kim MD, Tae I Kim MD, Won H Kim MD, Young-Ho Kim MD, Hyo J Kim MD, Suk-Kyun Yang MD, Seung-Jae Myung MD, Jeong-Sik Byeon MD, Moon S Lee MD, Il K Chung MD, Sung-Ae Jung MD, Yoon T Jeen MD, Jai H Choi MD, Kyu Y Choi MD, Hwang Choi MD, Dong S Han MD and Jae S Song MD
Am J Gastroenterol 101: 1333-1341; doi:10.1111/j.1572-0241.2006.00638.x
Temporal Trend in Relative Risk of Second Primary Colorectal Cancer
Ananya Das MD, Amitabh Chak MD and Gregory S Cooper MD
Am J Gastroenterol 101: 1342-1347; doi:10.1111/j.1572-0241.2006.00580.x
Pancreas
Timing of Antibiotic Prophylaxis in Acute Pancreatitis: A Controlled Randomized Study with Meropenem
Gianpiero Manes MD, Ilaria Uomo MD, Antonella Menchise MD, Pier Giorgio Rabitti MD, Elisa Chiara Ferrara MD and Generoso Uomo MD
Am J Gastroenterol 101: 1348-1353; doi:10.1111/j.1572-0241.2006.00567.x
Pediatrics
Contribution of OCTN Variants Within the IBD5 Locus to Pediatric Onset Crohn's Disease
Umesh Babusukumar, Tao Wang, Erin McGuire, Ulrich Broeckel and Subra Kugathasan MD
Am J Gastroenterol 101: 1354-1361; doi:10.1111/j.1572-0241.2006.00564.x
Pathology
Assessment of Rectal Aberrant Crypt Foci by Standard Chromoscopy and its Predictive Value for Colonic Advanced Neoplasms
Kazuhiro Seike, Keiji Koda, Kenji Oda, Chihiro Kosugi, Kimio Shimizu, Masaki Nishimura, Masanobu Shioiri, Shigetsugu Takano, Hiroshi Ishikura and Masaru Miyazaki
Am J Gastroenterol 101: 1362-1369; doi:10.1111/j.1572-0241.2006.00578.x
Clinical Reviews
Recurrence of Diseases Following Orthotopic Liver Transplantation
David S Kotlyar BS, Mical S Campbell MD and K Rajender Reddy MD
Am J Gastroenterol 101: 1370-1378; doi:10.1111/j.1572-0241.2006.00586.x
Case-Control Genetic Association Studies in Gastrointestinal Disease: Review and Recommendations
Yuri A Saito MD, MPH, Nicholas J Talley MD, PhD, Mariza de Andrade PhD and Gloria M Petersen PhD
Am J Gastroenterol 101: 1379-1389; doi:10.1111/j.1572-0241.2006.00587.x
Case Reports
Azathioprine Use During Pregnancy: Unexpected Intrauterine Exposure to Metabolites
Nanne K H de Boer MD, Soeresh V A Jarbandhan MD, Peer de Graaf MSc, Chris J J Mulder MD, PhD, Ruurd M van Elburg MD, PhD and Adriaan A van Bodegraven MD, PhD
Am J Gastroenterol 101: 1390-1392; doi:10.1111/j.1572-0241.2006.00538.x
Self-Expanding Metal Stents for the Treatment of Intrathoracic Esophageal Anastomotic Leaks Following Esophagectomy
Job H C Peters MD, Mikael E Craanen MD, PhD, Donald L van der Peet MD, PhD, Miguel A Cuesta MD, PhD and Chris JJ Mulder MD, PhD
Am J Gastroenterol 101: 1393-1395; doi:10.1111/j.1572-0241.2006.00615.x
Letters to the Editor
Metformin, Vitamin E, and Diet for Patients with Nonalcoholic Fatty Liver Disease
Abdurrahman Kadayifci MD and Raphael B Merriman MD
Am J Gastroenterol 101: 1396; doi:10.1111/j.1572-0241.2006.00595_1.x
Response to Letter
Elisabetta Bugianesi MD and Giulio Marchesini MD
Am J Gastroenterol 101: 1396-1397; doi:10.1111/j.1572-0241.2006.00595_2.x
Narcotic Use in Patients with Crohn's Disease
Timothy R Koch MD, FACG and David A Morowitz MD, FACG
Am J Gastroenterol 101: 1397; doi:10.1111/j.1572-0241.2006.00595_3.x
Narcotic Use in Patients with Crohn's Disease: Reply from Drs. Cross and Binion
Raymond K Cross MD and David G Binion MD
Am J Gastroenterol 101: 1397-1398; doi:10.1111/j.1572-0241.2006.00595_4.x
Eradication of Helicobacter pylori and Dosages of Esomeprazole
Gianpiero Manes MD, Elisa C Ferrara MD and Gabriele B Porro MD, PhD
Am J Gastroenterol 101: 1398-1399; doi:10.1111/j.1572-0241.2006.00595_5.x
The Optimal Dose of Esomeprazole for Anti-Helicobacter Pylori Therapy
Ping-I Hsu MD, Kwok-Hung Lai MD and Gin-Ho Lo MD
Am J Gastroenterol 101: 1399-1400; doi:10.1111/j.1572-0241.2006.00595_6.x
Colorectal Cancer Risk in Patients Affected with Crohn's Disease
Domenico Palli MD, Giovanna Masala MD, Francesco Sera PhD, Siro Bagnoli MD and Giuseppe d' Albasio MD
Am J Gastroenterol 101: 1400; doi:10.1111/j.1572-0241.2006.00595_7.x
Response to Letter
Tine Jess MD, Michael Gamborg MS, Peter Matzen MD, Pia Munkholm MD and Thorkild IA Sørensen MD
Am J Gastroenterol 101: 1400-1401; doi:10.1111/j.1572-0241.2006.00595_8.x
Inappropriate and Improper Use of Fecal Occult Blood Tests for Colorectal Cancer Screening in the VA Medical System
Furqaan Ahmed MD and Uma K Murthy MD
Am J Gastroenterol 101: 1401; doi:10.1111/j.1572-0241.2006.00595_9.x
Erratum
Erratum FREE
Am J Gastroenterol 101: 1402; doi:10.1111/j.1572-0241.2006.00767.x
